These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 12224013

  • 1. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine.
    Yei S, Bartholomew RM, Pezzoli P, Gutierrez A, Gouveia E, Bassett D, Soo Hoo W, Carlo DJ.
    Gene Ther; 2002 Oct; 9(19):1302-11. PubMed ID: 12224013
    [Abstract] [Full Text] [Related]

  • 2. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W, Lundeen KA, Kohrumel JR, Pham NL, Brostoff SW, Bartholomew RM, Carlo DJ.
    J Immunol; 1999 Jun 15; 162(12):7343-9. PubMed ID: 10358185
    [Abstract] [Full Text] [Related]

  • 3. Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine.
    Kayaga J, Souberbielle BE, Sheikh N, Morrow WJ, Scott-Taylor T, Vile R, Chong H, Dalgleish AG.
    Gene Ther; 1999 Aug 15; 6(8):1475-81. PubMed ID: 10467372
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A new mouse model of experimental melanoma for vaccine and lymphokine therapy.
    Shrayer DP, Bogaars H, Wolf SF, Hearing VJ, Wanebo HJ.
    Int J Oncol; 1998 Aug 15; 13(2):361-74. PubMed ID: 9664134
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y, Kono T, Yasumoto R, Kishimoto T, Wang CY, Haas GP, Nishisaka N.
    J Immunother; 2001 Aug 15; 24(3):205-11. PubMed ID: 11394497
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH, Chen Y, Chang CJ, Tai KF, Lin SM, Hwang LH.
    Clin Cancer Res; 2005 Feb 15; 11(4):1639-49. PubMed ID: 15746069
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC.
    Cancer Res; 2000 Mar 15; 60(6):1663-70. PubMed ID: 10749137
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunization of mice with irradiated melanoma tumor cells transfected to secrete lymphokines and coupled with IL-2 or GM-CSF therapy.
    Shrayer DP, Bogaars H, Hearing VJ, Wanebo HJ.
    J Exp Ther Oncol; 1996 Mar 15; 1(2):126-33. PubMed ID: 9414396
    [Abstract] [Full Text] [Related]

  • 17. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
    Ling X, Wang Y, Dietrich MF, Andreeff M, Arlinghaus RB.
    Oncogene; 2006 Jul 27; 25(32):4483-90. PubMed ID: 16547503
    [Abstract] [Full Text] [Related]

  • 18. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ, Kim JH, Lee YS, Kim J, Suh BS, Kim H, Cho S, Sohn JH, Kim GE, Yun CO.
    Gene Ther; 2006 Jul 27; 13(13):1010-20. PubMed ID: 16525479
    [Abstract] [Full Text] [Related]

  • 19. [The anti-tumor activity of GM-CSF-modified lung cancer cell vaccine and its synergism in combination with chemotherapy].
    Jiang HJ, Ren XB, Li H, Yu JP, Wei F, Ma MQ.
    Zhonghua Zhong Liu Za Zhi; 2007 Nov 27; 29(11):808-12. PubMed ID: 18396635
    [Abstract] [Full Text] [Related]

  • 20. Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb.
    Li B, Lin J, Vanroey M, Jure-Kunkel M, Jooss K.
    Clin Immunol; 2007 Oct 27; 125(1):76-87. PubMed ID: 17706463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.